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Modern medical advances in organ transplantation, medical devices, cancer chemotherapy etc. involve antibiotics to prevent and treat bacterial infections. Without effective antibiotics even minor infections can become high risk procedures. Antimicrobial resistance related infections are increasing with numbers suggesting that up to 50,000 lives are lost each year in Europe and the US alone and this could reach 10 million worldwide deaths each year. Adherence of bacteria to implanted medical devices or damaged tissue (wound healing) can become a cause of persistent infections. Bacteria have developed mechanisms by which they can circumvent the effects of antibiotics by forming a slimy layer known as biofilm that can induce subsequent infections and resistance to further antibiotic therapy. The global increase in antibiotic resistance is a major public health threat of the modern world including the UK, Australia and India. Our objective was to develop an alternative to antibiotics in treating device mediated infections. Gallium has been previously reported to suppress biofilm formation and growth of bacteria. Moreover, Ga3+ ions can block Fe3+ ion dependent processes because unlike Fe3+, Ga3+ cannot be reduced under the same conditions but sequential oxidation and reduction are essential for many of the biological functions of Fe3+ and crucial energy metabolism of bacteria. Out of different antibacterial formulations prepared, gallium-lactoferrin complex and gallium-curcumin complex exhibited the maximum antibacterial property. Gallium-lactoferrin complex significantly inhibited the biofilm formation when compared to silver ions and tobramycin. These formulations have the potential in the treatment of chronic non healing ulcers and can be used as antibacterial coatings on medical devices.


